Interferon therapy and its association with depressive disorders – A review
Open accessThe DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Abstract
Interferons (IFNs) are important in controlling the innate immune response to viral infections. Besides that, studies have found that IFNs also have antimicrobial, antiproliferative/antitumor and immunomodulatory effects. IFNs are divided into Type I, II and III. Type I IFNs, in particular IFN-α, is an approved treatment for hepatitis C. However, patients developed neuropsychological disorders during treatment. IFN-α induces proinflammatory cytokines, indoleamine 2,3-dioxygenase (IDO), oxidative and nitrative stress that intensifies the body’s inflammatory response in the treatment of chronic inflammatory disease. The severity of the immune response is related to behavioral changes in both animal models and humans. Reactive oxygen species (ROS) is important for synaptic plasticity and long-term potentiation (LTP) in the hippocampus. However, excess ROS will generate highly reactive free radicals which may lead to neuronal damage and neurodegeneration. The limbic system regulates memory and emotional response, damage of neurons in this region is correlated with mood disorders. Due to the drawbacks of the treatment, often patients will not complete the treatment sessions, and this affects their recovery process. However, with proper management, this could be avoided. This review briefly describes the different types of IFNs and its pharmacological and clinical usages and a focus on IFN-α and its implications on depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One specific cytokine, IL-1β, activates the kynurenine pathway in human hippocampal progenitor cells and contributes to the reduction of neurogenesis.”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TNF-α, a pro-inflammatory cytokine, induces excitotoxic damage to surrounding neurons by activating microglia, which in turn promote the release of glutamate.”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent potentiation in hippocampal neurons, which are responsible for memory storage, will lead to their damage by type I interferons, leading to depressive-like behaviour [55,56].”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“TNF-α can reduce tight junction protein expression, resulting in the increase of the permeability of the blood–brain barrier (BBB) and leading to larger gaps between the endothelial cells and a consequent loss of BBB integrity.”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Glutamate as a neurotransmitter in the healthy brain
Zhou, Y., & Danbolt, N. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1180-8 · Cited by 979
A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
Chronic stress, cognitive functioning and mental health
Marin, M.-F., Lord, C., Andrews, J., Juster, R.-P., Sindi, S., Arsenault-Lapierre, G., Fiocco, A. J., & Lupien, S. J. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.016 · Cited by 654
Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases
Kak, G., Raza, M., & Tiwari, B. K. (2018) · Biomolecular Concepts · doi:10.1515/bmc-2018-0007 · Cited by 617
Complex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101298 · Cited by 450
Research works printed but not linked: 2
- Greenberg, 2000, ‘Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes’, Cancer, 89, 10.1002/1097-0142(20000715)89:2<356::aid-cncr21>3.0.co;2-z · doi:10.1002/1097-0142(20000715)89:2<356::aid-cncr21>3.0.co;2-z
- Thau, 2022, Physiology, cortisol
Cited by
Lei, A. A., Phang, V. W. X., Lee, Y. Z., Kow, A. S. F., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072940 · Cited by 207
“Persistent potentiation in hippocampal neurons, which are responsible for memory storage, will lead to their damage by type I interferons, leading to depressive-like behaviour [55,56].”
Self-citationLiang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12010184 · Cited by 68
“Several hypotheses have been proposed regarding the underlying mechanisms of depression, including the monoamine hypothesis, neuroinflammation and oxidative damage, HPA axis abnormalities, and the neurogenesis hypothesis [2–4].”
BackgroundSelf-citationInnate immunity and interferon in SARS-CoV-2 infection outcome
Savan, R., & Gale, M. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.018 · Cited by 54
Neuroimmune modulation in liver pathophysiology
Zou, J., Li, J., Wang, X., Tang, D., & Chen, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03181-w · Cited by 43
Palepu, M. S. K., Bhalerao, H. A., Sonti, R., & Dandekar, M. P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176960 · Cited by 39
Metadata
- Authors
- Lai, J. Y., Ho, J. X., Kow, A. S. F., Liang, G., Tham, C. L., Ho, Y.-C., & Lee, M. T.
- Affiliations
- UCSI University (MY)
- Universiti Putra Malaysia (MY)
- I-Shou University (TW)
- Corresponding author
- Ho, Yu-Cheng
- Lee, Ming Tatt
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-02-22
- Volume
- 14
- Pages
- 1048592-1048592
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9992192
- OpenAlex
- W4321498954
- Semantic Scholar
- d76ad389ebcd6bb5a9d0263eae5526170b6b1e05
- Cited by
- 46
- References
- 102
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 10 · 2023: 8
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Higher Education, Malaysia (FRGS/1/2021/WAB13/UCSI/02/1)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- interferon therapy, interferon-alpha, depressive disorders, hepatitis C treatment, neuropsychiatric adverse effects, oxidative stress, reactive oxygen species, neuroinflammation, indoleamine 2,3-dioxygenase, limbic system, medication adherence, mood disorders
- MeSH terms
- Animals, Depressive Disorder, Humans, Interferon Type I, Cytokines, Interferon-alpha, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon therapy and its association with depressive disorders – A review. https://app.cochat.ai/papers/10.3389/fimmu.2023.1048592
- The paper
- Lai, J. Y., Ho, J. X., Kow, A. S. F., Liang, G., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2023). Interferon therapy and its association with depressive disorders – A review. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1048592
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.